Total Payments
$693.11
2024 Payments
$39.44
Companies
16
Transactions
39
Medicare Patients
473
Medicare Billing
$33,403
Payment Breakdown by Category
Food & Beverage$660.84 (95.3%)
Education$32.27 (4.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $660.84 | 38 | 95.3% |
| Education | $32.27 | 1 | 4.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $169.50 | 10 | $0 (2021) |
| Novo Nordisk Inc | $124.99 | 7 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $103.72 | 5 | $0 (2021) |
| Insulet Corporation | $59.65 | 3 | $0 (2024) |
| DEXCOM, INC. | $44.36 | 3 | $0 (2021) |
| Ascensia Diabetes Care US Inc. | $20.91 | 1 | $0 (2021) |
| Tandem Diabetes Care, Inc. | $20.59 | 1 | $0 (2019) |
| Mannkind Corporation | $20.35 | 1 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $18.58 | 1 | $0 (2020) |
| Zealand Pharma US, Inc. | $18.57 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $39.44 | 2 | Insulet Corporation ($25.76) |
| 2021 | $260.18 | 16 | Lilly USA, LLC ($99.03) |
| 2020 | $325.53 | 17 | Novo Nordisk Inc ($82.89) |
| 2019 | $67.96 | 4 | Lilly USA, LLC ($30.17) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/02/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $25.76 | General |
| Category: Insulin Pump | ||||||
| 10/11/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Endocrinology | ||||||
| 11/11/2021 | Medtronic, Inc. | InPen (Device) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 06/20/2021 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Diabetes | ||||||
| 06/10/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/07/2021 | Xeris Pharmaceuticals, Inc. | GVOKE PFS (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: DIABETES | ||||||
| 06/04/2021 | DEXCOM, INC. | DEXCOM G6 TRANSMITTER (Device) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/03/2021 | Ascensia Diabetes Care US Inc. | — | Food and Beverage | In-kind items and services | $20.91 | General |
| 05/28/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Diabetes | ||||||
| 05/14/2021 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Diabetes | ||||||
| 04/23/2021 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Diabetes | ||||||
| 04/21/2021 | Lilly USA, LLC | HUMULIN (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Diabetes | ||||||
| 04/14/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: Diabetes | ||||||
| 04/08/2021 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $15.72 | General |
| Category: Insulin Pump | ||||||
| 03/22/2021 | Lilly USA, LLC | HUMULIN (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: Diabetes | ||||||
| 03/15/2021 | DEXCOM, INC. | DEXCOM G6 TRANSMITTER (Device) | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/08/2021 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Obesity | ||||||
| 01/05/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: Diabetes | ||||||
| 11/09/2020 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $17.14 | General |
| 10/15/2020 | Zealand Pharma US, Inc. | V-GO (Device) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: 1 | ||||||
| 10/12/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/07/2020 | Dexcom, Inc. | DEXCOM G6 CGM SYSTEM (Device) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/30/2020 | Novo Nordisk Inc | — | Education | In-kind items and services | $32.27 | General |
| 08/17/2020 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: Cardiology | ||||||
| 08/06/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 7 | 211 | 244 | $37,736 | $12,913 |
| 2020 | 7 | 262 | 332 | $52,229 | $20,489 |
Total Patients
473
Total Services
576
Medicare Billing
$33,403
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 63 | 81 | $18,387 | $6,682 | 36.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 27 | 27 | $8,424 | $2,924 | 34.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 14 | 15 | $4,755 | $1,605 | 33.8% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 24 | 30 | $2,070 | $758.87 | 36.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 11 | 11 | $1,430 | $447.77 | 31.3% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 37 | 41 | $1,968 | $374.80 | 19.0% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2021 | 35 | 39 | $702.00 | $120.05 | 17.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 74 | 112 | $22,624 | $8,442 | 37.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 54 | 54 | $16,848 | $5,694 | 33.8% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 41 | 55 | $7,150 | $4,305 | 60.2% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2020 | 24 | 34 | $2,346 | $937.75 | 40.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 13 | 15 | $1,305 | $756.27 | 58.0% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 27 | 28 | $1,344 | $249.99 | 18.6% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2020 | 29 | 34 | $612.00 | $104.10 | 17.0% |
About Dr. Devika Madhavan, MD
Dr. Devika Madhavan, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/24/2014. The National Provider Identifier (NPI) number assigned to this provider is 1972923274.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Devika Madhavan, MD has received a total of $693.11 in payments from pharmaceutical and medical device companies, with $39.44 received in 2024. These payments were reported across 39 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($660.84).
As a Medicare-enrolled provider, Madhavan has provided services to 473 Medicare beneficiaries, totaling 576 services with total Medicare billing of $33,403. Data is available for 2 years (2020–2021), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Austin, TX
- Active Since 04/24/2014
- Last Updated 09/30/2021
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1972923274
Products in Payments
- FARXIGA (Drug) $103.72
- TRULICITY (Drug) $78.67
- Ozempic (Drug) $60.76
- Omnipod (Device) $59.65
- HUMULIN (Drug) $39.14
- DEXCOM G6 TRANSMITTER (Device) $29.94
- BAQSIMI (Drug) $23.16
- t-slim insulin pump (Device) $20.59
- AFREZZA (Drug) $20.35
- V-GO (Device) $18.57
- Saxenda (Drug) $17.76
- Vascepa (Drug) $17.48
- Minimed 670G System (Device) $17.20
- GVOKE PFS (Drug) $16.74
- DEXCOM G6 CGM SYSTEM (Device) $14.42
- InPen (Device) $14.00
- Korlym (Drug) $13.68
- Repatha (Biological) $12.79
- JARDIANCE (Drug) $11.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Austin
Dr. Thomas Blevins, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $1.5M
Endocrinology, Diabetes & Metabolism $1.5M
Michele Mcdermott, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $137,974
Endocrinology, Diabetes & Metabolism $137,974
Tira Chaicha-Brom, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $56,872
Endocrinology, Diabetes & Metabolism $56,872
Dr. Simona Scumpia, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $52,573
Endocrinology, Diabetes & Metabolism $52,573
Dr. Padma Horvit, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $20,822
Endocrinology, Diabetes & Metabolism $20,822
Farheen Yousuf, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $9,161
Endocrinology, Diabetes & Metabolism $9,161